Excretion and Biotransformation of Carboxymethyl-cysteine in Rat, Dog, Monkey and Man
Overview
Toxicology
Affiliations
1. Following an oral dose of S-carboxymethyl [35S]cysteine monkey (rhesus and African green), rat, dog, and man excreted 77,88,95, and 100% respectively of the 35S radioactivity in urine and 7.0, 2.5, 0.7, and 0.3% in faeces during a 3 to 4 day period. 2. The principal drug-related components excreted were unchanged carboxymethylcysteine, dicarboxymethyl sulphide and inorganic sulphate. 3. Rat, dog, and man excreted primarily dicarboxymethyl sulphide and unchanged carboxymethylcysteine and no inorganic sulphate (rat, 7%). 4. Monkey excreted largely inorganic sulphate, moderate amounts of dicarboxymethyl sulphide and a trace of unchanged drug.
Variation in human metabolism of S-carboxymethylcysteine.
Waring R Eur J Drug Metab Pharmacokinet. 1980; 5(1):49-52.
PMID: 7389752 DOI: 10.1007/BF03189444.
Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
Mitchell S, Waring R, Haley C, Idle J, Smith R Br J Clin Pharmacol. 1984; 18(4):507-21.
PMID: 6487492 PMC: 1463607. DOI: 10.1111/j.1365-2125.1984.tb02498.x.
Karim E, Millership J, Temple D, Woolfson A Eur J Drug Metab Pharmacokinet. 1988; 13(4):253-6.
PMID: 3243319 DOI: 10.1007/BF03190087.
High pressure liquid chromatographic determination of carbocisteine in human plasma and urine.
Bron J Pharm Weekbl Sci. 1986; 8(2):134-8.
PMID: 3086832 DOI: 10.1007/BF02086147.
Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.
Brockmoller J, Staffeldt B, Roots I Eur J Clin Pharmacol. 1991; 40(4):387-92.
PMID: 2050173 DOI: 10.1007/BF00265849.